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joint space narrowing (JSN) decreased 0.89 times per pmol/ml increase in
SF ARGS; without ROA at examination A the decrease in risk was 0.77, and
with ROA at examination A the association was not signiﬁcant (Table 1).
No association was found between SF ARGS and progression of osteophytes
or progression of ROA deﬁned as progression in either or both JSN and
osteophytes. Analysis without adjustments by univariate logistic regression
did not change these results.
Conclusions: In this longitudinal study of a cohort with previous knee
meniscectomy, higher SF ARGS levels were weakly associated with less
progression of radiographic knee OA.
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Purpose: To investigate systemic inﬂammation and autoimmune response
to citrullinated peptides in patients with erosive and non erosive “lone”
hand osteoarthritis (HOA) with no hip/knee involvement and their rela-
tionship with radiographic structural damage.
Methods: Sera were obtained from a total of 99 patients (3 males and 96
females, age range 50-88 years, mean 65 years) with HOA (52 patients
with erosive HOA and 47 patients with non erosive HOA) and from 50
controls subjects (NC) (2 males, 48 females, age range 51-86 years, mean
65 years). Hand OA diagnosis was made according to the American College
of Rheumatology Clinical Criteria for Hand OA. Plain hand radiographs were
obtained from all patients. All radiographs were scored for joint damage
following the Kellgren-Lawrence and the Kallman scores. Patients were
included in erosive HOA subsets according to the presence of well deﬁned
typical erosive changes (gull-wing and saw-tooth appearance) in two or
more digits. Serum levels of high sensitive CRP (hsCRP), IL-6, anti-CCP and
anti-Modiﬁed Citrullinated Vimentin (MCV) antibodies were evaluated by
commercial sandwich enzyme immunoassay (ELISA) kits. PTX3 was de-
tected by a sandwich ELISA based on a monoclonal antibody (mAb) MNB4
(ascites diluted 1:5000 in coating buffer) and rabbit antiserum as previously
described. Non-parametric data analysis was performed by Kruskal-Wallis
test with Dunn’s multiple comparison post-hoc test. Spearman’s correlation
analysis was used to assess relationships between variables. Statistical
Analysis was carried out using the GraphPad Prism for Windows (CA, USA).
Results: Circulating levels of inﬂammatory biomarkers hsPCR, IL-6 and
PTX3 were not signiﬁcantly different in two groups of patients with erosive
and non erosive HOA compared to NC and no signiﬁcant difference was
seen between non erosive and erosive HOA. Anti-CCP positivity were
detected respectively in 1/47 (2.1%) patient with non erosive HOA and in
1/52 (1.9%) erosive HOA patient. Anti-MCV antibodies were present in 4/47
(8.5%) patients with non erosive HOA, and 4/52 (7.7%) erosive HOA patients.
In the control group, one subject (2%) was positive for anti-CCP and 2
subjects (4%) had anti MCV antibodies. Signiﬁcant correlation was obtained
only between body mass index and hsCRP concentration (r = 0.2569; p =
0.0115) No correlation between inﬂammation markers/autoantibodies and
disease duration and radiological scores was found.
Conclusions: These results conﬁrm the association between BMI and CRP
and underline the lack of systemic inﬂammation in “lone” HOA. A small
minority of HOA patients circulate anti MCV antibodies.
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Introduction: Bone remodeling in osteoarthritis (OA) changes the shape
of articulating bone surfaces. This phenomenon has been demonstrated in
plain ﬁlms and more recently in MRI studies, where novel measurements
such as subchondral bone plate curvature have been introduced. There are,
however, very few attempts to establish their association to traditional
plain radiographic measurements.
Objective: To assess the association of an automated MRI-Atlas-based
standardized quantiﬁcation of bone curvature to traditional X-Ray based
measurements.
Methods: The baseline, 12 month and 24 month DESS sagittal MRI knee
images of 133 subjects from the OAI progression cohort releases: 0.C.2,
1.C2, 3.C.1 were automatically segmented to extract the cartilage plates and
bones using an automated atlas segmentation algorithm. Once segmented,
all the segmentations were evaluated for quality; 4 subjects had to be re-
moved due to large segmentations errors. Using the atlas deformations 3D
map, the subchondral bone curvatures were mapped back to the anatomic
atlas space and were compared point by point to the atlas subchondral
bone curvatures. Differences in the atlas and the subject curvatures’ values
were statistically described by mean, variance and percentiles of curvature
values for cMF, cLF, MT, LT, F, T, medial WB, lateral WB, and the entire tibia
femoral joint (TF). A linear regression model adjusted for subject height was
used to compare the paired KL scores, the JSN OARSI scores, and the average
joint space width to the curvature measurements of the 133 subjects. The
radiological data was provided by the OAI site (http://www.oai.ucsf.edu).
Results: Table 1 shows the results of the quantitative analysis.
Table 1. The average value, the standard deviation and the average curvature of the val-
ues higher than the 95% percentile were compared to the paired KL scores, the medal JSN
OARSI score and the average medial joint space width (JSW)
*Indicates adjusted correlations coeffcients statistically different from zero (p<0.05).
Conclusions: The Atlas-based curvature measurements generated at least
6 MRI-Atlas-based metrics that associate moderately to the radiological
severity of OA (0.49 ≥ r > 0.40) as measured by KL scores and correlate
weakly to the medial JSN OARSI scores and to the JSW (r<0.34). This
result provides supporting evidence that subchondral bone curvature is a
potential marker to stage the severity of OA.
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Introduction: Osteoarthritis (OA) is characterized by changes in all struc-
tures in an involved joint, including articular cartilage, menisci, subchondral
bone, and subchondral bone plate, (SCBP). Understanding the evolution
and interplay of these changes would provide an understanding of the
pathophysiology of OA and help establish the eﬃcacy of therapies aimed at
preventing, halting or reversing structural damage. Although most research
into OA has focused on the articular cartilage, there is increasing evidence
of the signiﬁcant role of SCBP changes in the disease progression.
Objective: To evaluate the rate of change and the sensitivity of atlas-based
standardized measures of SCBP’s curvature in subjects with OA symptoms
but no plain radiographic evidence of OA.
Methods: The baseline, 12 month and 24 month sagittal 3D DESS WE MRI
knee images of 133 subjects from the OAI progression cohort releases:
0.C.2, 1.C2, 3.C.1 were segmented into bone and cartilage using a fully
automated atlas-based segmentation algorithm. Once segmented, all the
segmentations were evaluated for quality and four subjects were removed
due to large segmentations errors. Using the atlas deformations 3D map,
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the subchondral bone plate shapes’ curvatures were mapped back to the
reference atlas space and were compared point by point to the correspond-
ing curvatures in the atlas. Once all curvatures measurements were mapped
on the atlas space they were compared to the baseline measurement doing
a point by point subtraction. Changes in curvature values from baseline
were statistically described by mean, variance and percentiles of changes
for each subject. The quantiﬁcation was done on the cMF, cLF, MT, T, F and
the entire tibio-femoral joint (TF). The paired KL scores of the 133 subjects
provided by the OAI site (http://www.oai.ucsf.edu) were used to identify
the subjects with no radiological evidence of OA (KL< 2). The longitudinal
data was analyzed using generalized least squares adjusted to JSN score
and height with a covariance structure grouped by subject and time as
continuous covariate. Furthermore, the proportion of subjects that changed
curvature metrics from 12 month to the 24 month was reported.
Results: From the 133 analyzed subjects, 18 subjects meet the analysis
criteria (KL<2). Table 1 shows the results of the quantitative analysis of
change in curvature.
Table 1. The annualized change, the standard deviation of the residuals, the annualized
standard response of the mean (SRM) and the proportion of subjects that changed mea-
surement from the 12 month to the 24 month
*Statistically different from zero (p<0.05). **Statistically different from 0.5 (p<0.05).
Conclusions: The results of this pilot study demonstrate statistically sig-
niﬁcant changes in the subchondral bone plate curvature in subjects with
clinical symptoms but no plain radiographic evidence of OA. The large
annual SRM (>0.8) observed for some biomarkers suggests that small
clinical trials can be used to test the eﬃcacy of physical or pharmaceutical
therapies aimed at preventing, halting or reversing the subchondral bone
changes associated with OA.
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Purpose: The aim of this study was to use high throughput proteomics
to identify the major proteins present in the secretome of an explant
model of canine articular cartilage and gain a fundamental understanding
of the proteome response to pro-inﬂammatory cytokines and non-steroidal
anti-inﬂammatory drugs.
Methods: We established an explant model of canine articular cartilage
from the stiﬂe joints of three German shepherd dogs euthanized for pur-
poses other than research. Three full depth cartilage discs were exercised
using a 3 mm biopsy punch and washed with PBS (containing 10% peni-
cillin and streptomycin). Explants were pre-incubated in serum-free DMEM
Abstract 121 – Table 1. Proteins identiﬁed in the secretome of canine cartilage using high-throughput proteomics
Protein Name Database Entry MASCOT Score Number of Peptides Functional Role
Cartilage oligomeric matrix protein precursor gi|73985933 1339 83 Structural integrity of ECM
Fibronectin 1 isoform 1 gi|74005698 1326 43 Matrix organisation
Aggrecan core protein precursor gi|12644429 1122 120 Compression resistance within the ECM
Chondroadherin precursor gi|73966365 470 15 Promotes attachment of ECM components
Matrix metalloproteinase 3 gi|50950195 500 21 Fibronectin degradation
Clusterin gi|50979240 451 11 ECM component
Decorin gi|50979008 310 16 Fibril formation within ECM
Thrombospondin-4 gi|311626 244 14 Cell-matrix interactions
Cartilage intermediate layer protein gi|74000887 186 6 Cartilage matrix organization
Biglycan gi|50979010 215 7 Collagen ﬁbre assembly
supplemented with 2% penicillin and streptomycin in a CO2 incubator
for 24 hours at 37°C. The explants were then incubated alone (control
media), or with recombinant canine IL-1β (10ng/ml), the non-steroidal
anti-inﬂammatory drug carprofen (Rimadyl, 1 mg/ml) or carprofen and IL-
1β combined (1 mg/ml and 10ng/ml respectively). After 5 days in culture,
cell-free supernatants were removed and three representative samples
were chosen from each treatment for proteomic analysis. Tryptic peptides
were separated on a 15 cm C18 PepMap™ column (LC packings) on a Bruker
Easy-nLC chromatography platform and detected in a Bruker amaZon ETD
ion trap instrument. The ﬁve most abundant peptides in each MS survey
scan were selected for fragmentation. Using the MASCOT search engine
the fragment patterns for each peptide were compared to the mammalian
entries in both the NCBInr and SwissProt databases. The modiﬁcations
incorporated into the search were: ﬁxed carbamidomethyl cysteine and
variable oxidation of methionine. In addition, the other parameters set
were: one missed cleavage site, one C13 and 0.5 Da for both MS and MS-MS
spectra.
Results: A number of cartilage-speciﬁc extracellular matrix proteins were
identiﬁed from the canine explant supernatants (Table 1). These in-
cluded cartilage oligomeric matrix protein (COMP), ﬁbronectin, biglycan,
chondroadherin precursor, matrix metalloproteinase 3, clusterin, decorin,
thrombospondin-4, cartilage intermediate layer protein CILP) and aggre-
can core protein precursor. These secreted proteins have previously been
identiﬁed in equine explant cultures in our laboratory.
Conclusions: This proteomic study has conﬁrmed the presence of a similar
set of proteins in the secretomes of canine and equine cartilage explant
models. Many of the proteins identiﬁed have well-established extracel-
lular matrix functions and are associated with matrix organisation and
cell-matrix interactions. The expression of some of the proteins identiﬁed
using this approach has been validated in equine explant supernatants
by quantitative western blotting. High-throughput proteomic analysis has
enabled detection of protein proﬁles within the secretome of a canine
cartilage explant model, similar to those in our equine explants studies. The
data presented supports the view that using high throughput proteomics
may be a useful strategy for studying dynamic changes in the secretome of
cartilage explants from species of interest in response to pro-inﬂammatory
cytokines, anti-inﬂammatory compounds and nutraceutical compounds
derived from non-protein sources.
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Purpose: In healthy cartilage there is a balance between synthesis and
degradation of extra cellular matrix components. In diseases such as OA
and in knee injuries this balance is disturbed and proteolytic cleavage of
aggrecan is seen as an early key event. Matrix metalloproteases (MMPs) and
aggrecanases are the major enzymes known to be involved in this degra-
dation. To understand the process of cartilage degradation it is important
to know where and in which preferred order the involved enzymes cleaves
aggrecan. This study was undertaken to investigate the time dependent
degradation of human aggrecan by MMP-3.
Methods: Human aggrecan was puriﬁed from a pool of adult knee OA
cartilage (n=10, from knee replacement surgery), from young (n=1) knee
healthy cartilage and from a pool of OA synovial ﬂuid (SF, n=47) by
guanidine extraction and CsCl density gradient centrifugation. Aggrecan
from OA cartilage (470 pmol) was digested by recombinant human MMP-3
(160 pmol) for up to 24h at 37°C. Samples were deglycosylated, sepa-
